CR
CRON.US Cronos Group Inc
- Market cap
- USD 1.24B
- P/E
- 21.1x
- P/B
- 1.17x
- ROE
- 7.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CRON.US undervalued?
Graham numberCRON.US trades 4.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cronos Group Inc fundamental analysis
No fundamental analysis for Cronos Group Inc yet.
Cronos Group Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cronos Group Inc
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
Full company profileCronos Group Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cronos Group Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 412K | 4.14M | 12.1M | 17.8M | 46.7M | 64.6M | 86.7M | 87.2M | 118M | 149M | 215M |
| Gross Profit | 1.48M | 2.00M | 6.21M | -13.2M | -25.8M | -17.6M | 15.4M | 11.9M | 25.2M | 61.7M | 106M |
| Operating Income | -2.13M | -7.78M | -20.4M | -118M | -219M | -292M | -111M | -84.8M | -76.5M | -17.8M | 20.3M |
| EBITDA | -851K | -5.35M | -18.8M | -115M | -66.0M | -150M | -91.3M | -71.8M | -50.2M | -3.36M | 43.1M |
| Net Income | -1.20M | 2.53M | -21.6M | 1.19B | -73.1M | -396M | -169M | -74.0M | 41.1M | -9.61M | 79.3M |
| EPS | -0.02 | 0.01 | -0.13 | 3.48 | -0.21 | -1.07 | -0.45 | -0.19 | 0.11 | -0.02 | 0.23 |
| Balance Sheet | |||||||||||
| Total Assets | 31.9M | 80.3M | 232M | 1.57B | 1.93B | 1.40B | 1.21B | 1.14B | 1.17B | 1.20B | 1.20B |
| Total Liabilities | 6.86M | 11.7M | 34.9M | 256M | 218M | 63.5M | 72.0M | 44.1M | 55.3M | 54.2M | 73.4M |
| Shareholders' Equity | 25.1M | 87.6M | 148M | 1.31B | 1.71B | 1.34B | 1.14B | 1.10B | 1.06B | 1.09B | 1.07B |
| Cash & Short-term Investments | 2.58M | 7.32M | 32.7M | 1.13B | 1.29B | 1.00B | 878M | 862M | 859M | 832M | 741M |
| Total Debt | 2.98M | 4.27M | 159K | 5.34M | 9.81M | 9.81M | 3.88M | 2.55M | 2.02M | 1.51M | 1.21M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -4.82M | -4.41M | -9.90M | -97.6M | -145M | -154M | -88.9M | -42.8M | 18.8M | 26.3M | 92.1M |
| Capital Expenditure | 1.13M | 34.0M | 84.3M | 29.3M | 35.4M | 12.3M | 5.03M | 3.42M | 13.2M | 26.2M | 18.1M |
| Free Cash Flow | -5.95M | -38.4M | -91.4M | -127M | -180M | -166M | -94.0M | -46.3M | 5.69M | 152K | 74.0M |
| Ratios | |||||||||||
| ROE | -4.8% | 2.9% | -14.6% | 90.8% | -4.3% | -29.6% | -14.8% | -6.7% | 3.9% | -0.9% | 7.4% |
| ROA | -3.8% | 3.1% | -9.3% | 76.0% | -3.8% | -28.3% | -13.9% | -6.5% | 3.5% | -0.8% | 6.6% |
| Net Profit Margin | -290.8% | 61.0% | -178.5% | 6,691.6% | -156.5% | -613.5% | -194.5% | -84.8% | 34.9% | -6.4% | 36.9% |
| Debt to Equity | 0.12x | 0.05x | 0.00x | 0.00x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cronos Group Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | USD 345K | 0.00 | - |
| 2022 | USD 384K | 0.00 | - |
| 2021 | - | - | - |
| 2020 | USD 2.61M | 0.01 | - |
| 2019 | USD 65.1M | 0.19 | 5.5% |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Cronos Group Inc
- Insiders 49.42%
- Institutions 16.35%
- Public & others 34.23%
- Shares outstanding 366M
- Free float 186M
Top funds holding CRON.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| ETFMG Alternative Harvest ETF | 3.49M | 0.95% | 0.00% | Oct 2026 |
| DFA International Core Equity 2 I | 953K | 0.26% | +2.41% | Sep 2026 |
| DFA International Small Company I | 912K | 0.25% | 0.00% | Sep 2026 |
| Global X Marijuana Life Sciences ETF | 903K | 0.25% | -19.52% | Sep 2026 |
| 1832 AM Quant Canadian Sm Cap Eq Pool KM | 763K | 0.21% | +43.11% | Sep 2026 |
| Mackenzie GQE Canadian Equity F | 749K | 0.20% | -6.95% | Aug 2026 |
| iShares Core MSCI Total Intl Stk ETF | 665K | 0.18% | 0.00% | Oct 2026 |
| Mackenzie GQE Canadian Balanced F | 626K | 0.17% | +4.48% | Aug 2026 |
| AdvisorShares Pure Cannabis ETF | 503K | 0.14% | 0.00% | Oct 2026 |
| USA Mutuals Vice Investor | 480K | 0.13% | 0.00% | Jun 2026 |
| DFA Canadian Core Equity Class F | 478K | 0.13% | 0.00% | Aug 2026 |
| Dimensional International Small Cap ETF | 457K | 0.12% | 0.00% | Oct 2026 |
| Dimensional International Core Eq 2 ETF | 433K | 0.12% | 0.00% | Oct 2026 |
| iShares Core MSCI Intl Dev Mkts ETF | 354K | 0.10% | 0.00% | Oct 2026 |
| DFA International Vector Equity I | 231K | 0.06% | +13.61% | Sep 2026 |
| Fidelity Nasdaq Composite ETF | 220K | 0.06% | 0.00% | Oct 2026 |
| Dimensional World ex US Core Eq 2 ETF | 207K | 0.06% | 0.00% | Oct 2026 |
| CANSOUL Fonds Hanf Aktien Global EUR C | 200K | 0.05% | 0.00% | Sep 2026 |
| Dimensional International Cr Eq Mkt ETF | 187K | 0.05% | 0.00% | Oct 2026 |
| iShares S&P/TSX Small Cap ETF | 160K | 0.04% | -1.45% | Oct 2026 |
Top institutions holding CRON.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| D. E. Shaw & Co LP | 8.84M | 2.41% | +16.04% | Jun 2026 |
| Chescapmanager LLC | 7.94M | 2.16% | 0.00% | Jun 2026 |
| Tidal Investments LLC. | 3.77M | 1.03% | -6.43% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 3.20M | 0.87% | +5.13% | Sep 2026 |
| Arrowstreet Capital Limited Partnership | 1.99M | 0.54% | 0.00% | Jun 2026 |
| Renaissance Technologies Corp | 1.74M | 0.47% | -13.31% | Jun 2026 |
| Mackenzie Investments | 1.60M | 0.43% | 0.00% | Jun 2026 |
| CIBC World Markets Inc. | 1.38M | 0.38% | +2.71% | Jun 2026 |
| Mmcap International Inc. Spc | 999K | 0.27% | 0.00% | Jun 2026 |
| Quinn Opportunity Partners LLC | 969K | 0.26% | 0.00% | Jun 2026 |
| Citadel Advisors Llc | 951K | 0.26% | +160.79% | Jun 2026 |
| Pillsbury Lake Capital LLC | 810K | 0.22% | -80.82% | Jun 2026 |
| Springbok Capital Management, LLC | 810K | 0.22% | -45.99% | Jun 2026 |
| Susquehanna International Group, LLP | 756K | 0.21% | -40.02% | Jun 2026 |
| Silver OAK Securities, INC. | 656K | 0.18% | +3.10% | Jun 2026 |
| Qube Research & Technologies | 642K | 0.17% | -24.07% | Jun 2026 |
| Jane Street Group LLC | 607K | 0.17% | -21.15% | Jun 2026 |
| Geode Capital Management, LLC | 577K | 0.16% | +4.65% | Jun 2026 |
| The Goldman Sachs Group Inc | 543K | 0.15% | +4.28% | Jun 2026 |
| UBS Group AG | 509K | 0.14% | +2.70% | Jun 2026 |
Cronos Group Inc company profile
- Company name
- Cronos Group Inc
- Ticker
- CRON.US
- ISIN
- CA22717L1013
- Exchange
- USA Stocks
- Listed since
- Jul 12, 2016
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 610
- Fiscal year end
- December
- Address
- 4491 Concession Road 12, Stayner, ON, Canada, L0M 1S0
- Phone
- 416 504 0004
- Website
- thecronosgroup.com
About Cronos Group Inc
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
Cronos Group Inc management
10- Mr. Michael Ryan Gorenstein J.D.President, CEO & Chairman · born 1987
- Ms. Anna ShlimakChief Financial Officer · born 1986
- Ms. Shannon BuggySenior VP & Global Head of People · born 1970
- Mr. Jeffrey David JacobsonChief Growth Officer · born 1986
- Mr. Adam WagnerGeneral Manager of Cronos Israel · born 1983
- Mr. Jared Matthew KenostVP, Principal Accounting Officer & Controller
- Mr. Harrison AaronSenior Director of Investor Relations & Corporate Development
- Mr. Terry Gregory-Joseph DoucetGeneral Counsel & Corporate Secretary · born 1990
- Mr. Arye WeigensbergSenior VP and Head of Research & Development · born 1983
- Christopher MartensGeneral Manager